Coronary Stents Market Research Report - Global Forecast till 2027

Coronary Stents Market Research Report: by Products (Drug Eluting Stents, Bare Metal Stents, and Bioresorbable Vascular Scaffolds), By End-Users (Hospitals and clinics, ambulatory surgical center, specialty center, and others) - Forecast Till 2030

ID: MRFR/MED/5473-HCR | October 2022 | Region: Global | 130 pages

Impact of COVID – 19 on Coronary Stents Market:


An estimated two million people get coronary artery stents every year, according to the Harvard Health School. The current outbreak of COVID - 19 has affected the coronary stents market in several ways. The business complexities arising from the current pandemic has created confusion with respect to the production of medical devices. The solution to various multifaceted uncertainties experienced by coronary stent manufacturers, hospitals, surgical centers, and organizations working in the supply chain of these medical devices are covered in the restructured research report.


Based on a longtime voluntary registry, founded by the German Society for Thoracic and Cardiovascular Surgery (GSTCVS), well-defined data of all cardiac, thoracic, and vascular surgery procedures performed in 78 German heart surgery departments during the year 2018 were analyzed. For this period, a total of 174,902 procedures were submitted to the registry, 98,707 summarized as heart surgery procedures and 942 assist device implantations were registered. The growth in the cardiac surgeries can be explained with the help of infographic below.


Impact of COVID-19 outbreak on cardiac surgery and coronary stent implants:


According to the PCROnline, cardiac surgery practice might not be on the frontline of COVID-19 patient care. However, the pandemic affects cardiac surgery units and coronary stent implants in several ways:



  • Limited intensive care unit (ICU) beds and ventilation sites

  • Necessity to postpone elective and/or complex cardiac surgeries

  • Shortage of healthcare workers

  • Restrictions in clinical meetings (e.g. limiting the number of attendees in heart-team meetings)

  • Patients with COVID-19 needing urgent cardiac operations

  • Cancelation of training and education, professional conferences, exams, and courses


Impact of COVID-19 outbreak on supply chain:


The disruption of the coronary stents market due to COVID-19 outbreak in select geographies is explained below. Procurement and supply of the raw materials, such as platinum and cobalt, required to produce stents have been affected due to a smaller number of freights operating between different continents. Many medical device manufacturing giants have headquarters and manufacturing facilities in different countries, which might lead to supply chain constraints. For instance, Boston Scientific’s headquarters in the US is supported by its manufacturing plants in the US, Ireland, and Malaysia to supply products around the globe.


The inventory of coronary stents by subsidiary companies in different countries are affected. For instance, due to reduced demand for coronary stent implant, the stock of products is not being sold. On the other hand, a subsidiary without manufacturing facility in respective country when imports the coronary stents for the patients, it increases the product cost and overall cost of procedures in select geographies.


Impact of COVID-19 outbreak due to delayed elective surgeries:


The focus of healthcare providers is primarily on the diagnosis and treatment of patients suffering from coronavirus. An urge from various national and regional governments to delay the elective surgeries has reduced the number of overall surgeries. The demand for medical devices is expected to shrink due to deferred elective surgeries.



  • Massachusetts General Hospital has announced hospital-wide cancellations of all elective surgeries starting March 23 until further notice.



  • The American College of Surgeons and the US surgeon general recommend that consideration be given to canceling elective surgeries countrywide.



  • Atlanta’s Gastroenterology Associates, which has backing from private equity firm Frazier Healthcare Partners, furloughed about 300 of its more than 800 employees after cutting elective surgeries, which account for nearly 80% of procedures.



  • The number of primary angioplasties, the main treatment for heart attack, dropped by 40% in Spain since the beginning of the lockdown.



  • In Jayadeva Hospital, Mysuru, an average of 40 to 50 patients used to undergo angiogram and 15 to 20 people were being installed stent per day. But now, hardly 10 to 15 people undergo angiogram and six patients are being installed stent since the lockdown.


The supply chain constraints coupled with delayed elective surgeries has affected the coronary stents market negatively. The government regulations affecting the coronary stents market are expected to inspire manufacturers take strategic decisions in respective countries.


below


Source: German Heart Surgery Report, German Society for Thoracic and Cardiovascular Surgery, MRFR Analysis